Literature DB >> 25320505

Subtotal gastrectomy for gastric cancer.

Roberto Santoro1, Giuseppe Maria Ettorre1, Eugenio Santoro1.   

Abstract

Although a steady decline in the incidence and mortality rates of gastric carcinoma has been observed in the last century worldwide, the absolute number of new cases/year is increasing because of the aging of the population. So far, surgical resection with curative intent has been the only treatment providing hope for cure; therefore, gastric cancer surgery has become a specialized field in digestive surgery. Gastrectomy with lymph node (LN) dissection for cancer patients remains a challenging procedure which requires skilled, well-trained surgeons who are very familiar with the fast-evolving oncological principles of gastric cancer surgery. As a matter of fact, the extent of gastric resection and LN dissection depends on the size of the disease and gastric cancer surgery has become a patient and "disease-tailored" surgery, ranging from endoscopic resection to laparoscopic assisted gastrectomy and conventional extended multivisceral resections. LN metastases are the most important prognostic factor in patients that undergo curative resection. LN dissection remains the most challenging part of the operation due to the location of LN stations around major retroperitoneal vessels and adjacent organs, which are not routinely included in the resected specimen and need to be preserved in order to avoid dangerous intra- and postoperative complications. Hence, the surgeon is the most important non-TMN prognostic factor in gastric cancer. Subtotal gastrectomy is the treatment of choice for middle and distal-third gastric cancer as it provides similar survival rates and better functional outcome compared to total gastrectomy, especially in early-stage disease with favorable prognosis. Nonetheless, the resection range for middle-third gastric cancer cases and the extent of LN dissection at early stages remains controversial. Due to the necessity of a more extended procedure at advanced stages and the trend for more conservative treatments in early gastric cancer, the indication for conventional subtotal gastrectomy depends on multiple variables. This review aims to clarify and define the actual landmarks of this procedure and the role it plays compared to the whole range of new and old treatment methods.

Entities:  

Keywords:  Endoscopy; Gastrectomy; Gastric cancer; Gastric stump cancer; Laparoscopy; Lymphadenectomy; Quality of life

Mesh:

Year:  2014        PMID: 25320505      PMCID: PMC4194551          DOI: 10.3748/wjg.v20.i38.13667

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  117 in total

1.  Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures.

Authors:  Jyewon Song; Sung Jin Oh; Wook Ho Kang; Woo Jin Hyung; Seung Ho Choi; Sung Hoon Noh
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

2.  Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan.

Authors:  Yuko Kitagawa; Hiroya Takeuchi; Yu Takagi; Shoji Natsugoe; Masanori Terashima; Nozomu Murakami; Takashi Fujimura; Hironori Tsujimoto; Hideki Hayashi; Nobunari Yoshimizu; Akinori Takagane; Yasuhiko Mohri; Kazuhito Nabeshima; Yoshikazu Uenosono; Shinichi Kinami; Junichi Sakamoto; Satoshi Morita; Takashi Aikou; Koichi Miwa; Masaki Kitajima
Journal:  J Clin Oncol       Date:  2013-09-09       Impact factor: 44.544

3.  [Progress in studies on stomach cancer in Japan].

Authors:  E Murakami; T Nagatomo; K Hori; N Asano; T Shirai
Journal:  Nihon Rinsho       Date:  1967-07

4.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

5.  Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program.

Authors:  E Bollschweiler; K Boettcher; A H Hoelscher; M Sasako; T Kinoshita; K Maruyama; J R Siewert
Journal:  Br J Surg       Date:  1992-02       Impact factor: 6.939

6.  Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.

Authors:  Jin-Pok Kim; Joo-Ho Lee; Soo-Jin Kim; Hang-Jong Yu; Han-Kwang Yang
Journal:  Gastric Cancer       Date:  1998-03       Impact factor: 7.370

7.  Low Maruyama index surgery for gastric cancer: blinded reanalysis of the Dutch D1-D2 trial.

Authors:  K C M J Peeters; S A Hundahl; E Klein Kranenbarg; H Hartgrink; C J H van de Velde
Journal:  World J Surg       Date:  2005-12       Impact factor: 3.352

8.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

9.  Sentinel node in gastric cancer surgery.

Authors:  M Carlini; F Carboni; M Petric; R Santoro; F Guadagni; F Marandino; M Castelli; E Santoro
Journal:  J Exp Clin Cancer Res       Date:  2002-12

10.  Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti; F Calvo
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  11 in total

1.  Risk factors for tuberculosis after gastrectomy in gastric cancer.

Authors:  Won Jai Jung; Young Mok Park; Joo Han Song; Kyung Soo Chung; Song Yee Kim; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Sung Hoon Noh; Ji Yeong An; Young Ae Kang
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

2.  Which are the best Chinese herbal injections combined with XELOX regimen for gastric cancer?: A PRISMA-compliant network meta-analysis.

Authors:  Dan Zhang; Jiarui Wu; Kaihuan Wang; Xiaojiao Duan; Shi Liu; Bing Zhang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

3.  The application of nalbuphine in patient-controlled intravenous analgesia for patients undergoing subtotal gastrectomy.

Authors:  Li Yang; Jinjing Wu; Tao Li
Journal:  Exp Ther Med       Date:  2017-12-14       Impact factor: 2.447

4.  Is endoscopic surveillance necessary for patients who undergo total gastrectomy for gastric cancer?

Authors:  Sung Jae Park; Young Soo Park; In Sub Jung; Hyuk Yoon; Cheol Min Shin; Sang-Hoon Ahn; Do Joong Park; Hyung Ho Kim; Nayoung Kim; Dong Ho Lee
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

5.  Gastric Schwannoma: A Case Report and Review of the Literature for Gastric Submucosal Masses Distinction.

Authors:  Behnam Sanei; Amirhosein Kefayat; Melika Samadi; Parvin Goli; Mohammad Hossein Sanei; Mahsa Khodadustan
Journal:  Case Rep Med       Date:  2018-04-10

Review 6.  Intraoperative Tumor Localization of Early Gastric Cancers.

Authors:  Sang-Ho Jeong; Kyung Won Seo; Jae-Seok Min
Journal:  J Gastric Cancer       Date:  2021-03-23       Impact factor: 3.720

7.  Analysis of the Occurrence of Diseases Following Gastrectomy for Early Gastric Cancer: a Nationwide Claims Study.

Authors:  Ho Seok Seo; Yewon Na; Jaehun Jung
Journal:  J Gastric Cancer       Date:  2021-10-01       Impact factor: 3.720

Review 8.  Ferroptosis and its Role in Gastric Cancer.

Authors:  Renjun Gu; Yawen Xia; Pengfei Li; Defang Zou; Keqin Lu; Lang Ren; Hongru Zhang; Zhiguang Sun
Journal:  Front Cell Dev Biol       Date:  2022-06-30

9.  Gastric Metastasis of Primary Lung Cancer: Case Report and Systematic Review With Pooled Analysis.

Authors:  Dong Tang; Jianjian Lv; Zhijing Liu; Shuhui Zhan; Yuqiang Gao
Journal:  Front Oncol       Date:  2022-07-08       Impact factor: 5.738

Review 10.  Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies.

Authors:  Julita Machlowska; Jacek Baj; Monika Sitarz; Ryszard Maciejewski; Robert Sitarz
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.